Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Baron Health Care Fund Q4 2025 Contributors And Detractors
10:18am, Tuesday, 03'rd Mar 2026
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the com
The Best Healthcare Stock to Invest $1,000 in Right Now
03:00pm, Monday, 02'nd Mar 2026
Teva Pharmaceutical Industries has more than doubled in price over the past year. The Israeli drugmaker, formerly known for producing generics, has made a major move into the specialty drugs space.
Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole
06:22pm, Friday, 27'th Feb 2026
Teva Pharmaceutical Industries is a large manufacturer of generic drugs. The company is working to expand into more complex generics and to develop its own drugs.
Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors
07:05pm, Thursday, 26'th Feb 2026
Investor attention turned more intensely to the scale, timing, and funding of AI-related capital commitments, prompting renewed debate about whether expectations were running ahead of eventual monetiz
Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 25'th Feb 2026
Here is how Teva Pharmaceutical Industries Ltd. (TEVA) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.
Teva to Present at the Upcoming Investor Conferences in March
04:30pm, Tuesday, 24'th Feb 2026
PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will
PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (E
Teva Pharmaceutical Industries (TEVA) Upgraded to Buy: Here's What You Should Know
01:01pm, Friday, 20'th Feb 2026
Teva Pharmaceutical Industries (TEVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
Corcept Therapeutics Stock Plunges As Court Clears Teva Generic
11:48am, Thursday, 19'th Feb 2026
Corcept had argued that Teva's label for its generic version of Korlym, a drug used to treat Cushing's syndrome, would induce doctors to follow patented dosing methods involving mifepristone and stron
Market Today: Moderna rebounds; oil and gold jump
05:34pm, Wednesday, 18'th Feb 2026
Guru Stock PicksLouis Moore Bacon has made the following transactions:Reduce in XLF by 69.62%Sold out in CEGAdd in CLS by 386.7%New position in CLJoel Greenblat
Larry Robbins Exits Universal Health Services Inc, Impacting Portfolio by -2.19%
06:13pm, Tuesday, 17'th Feb 2026
Insights into Glenview Capital Management's Fourth Quarter 2025 Moves Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the fourth quarte
Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript
10:54am, Tuesday, 17'th Feb 2026
Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript
Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients
07:04am, Tuesday, 17'th Feb 2026
Teva and Sanofi SA (NASDAQ: SNY) released positive results on Tuesday from the RELIEVE UCCD long-term extension study of duvakitug, an investigational human monoclonal antibody targeting TL1A.
Teva will hold an investor call and live webcast today, Tuesday, February 17, 2026, at 8:00 a.m. ET to discuss these data.
Thrivent Financial for Lutherans Buys Shares of 199,467 Teva Pharmaceutical Industries Ltd. $TEVA
04:18am, Sunday, 08'th Feb 2026
Thrivent Financial for Lutherans purchased a new position in shares of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in the third quarter, according to the company in its most recent filing with th
